TOMORROW: Join us for a Facebook Live Q&A with lung cancer patient and advocate Lisa Goldman and ALCF’s Director of Science and Research Dr. Amy Moore as they provide updates on a groundbreaking patient-driven research initiative to bring ROS1-affected lung cancer out of obscurity and into a known and manageable condition. Though this session is focused on the ROS1 gene, all lung cancer patients are encouraged to participate! #BeatLungCancer
Join us February 21 on Facebook Live a... - Lung Cancer Support
Join us February 21 on Facebook Live at 1:30 PM
Written by
KimGO2
Partner
To view profiles and participate in discussions please or .
2 Replies
•
I have a very important question to ask I wish you would get back to me. Thank you susiejo1948ⁿ
Not what you're looking for?
You may also like...
Farewell to our dear friend Anita
with the (then) Addario Lung Cancer Foundation.
Anita was a fierce advocate who fought for the...
Please join us for June 8 for a discussion of molecular subsets of NSCLC (EGFR, ROS1, ALK, etc)
OCE Listening Session: “Drug Development in Molecular Subsets of Non-Small Cell Lung Cancer, Part...
First Targeted Adjuvant Therapy for EGFR Non Small Cell Lung Cancer (stage IB-IIIA)
non-small cell lung cancer (NSCLC) that has been surgically removed, when the cancer has a change in
Stage IV Lung Cancer Diagnosed/ Life Expectancy
However, after doing research and reading many post of people with the same Lung Cancer IV. I've...
Has anyone received the Covid-19 Vaccine while taking Immunotherapy?
and other patients have been receiving this therapy longer than metastatic lung cancer patients...